Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors

NCT06929325 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

HR+/HER2- Advanced/Metastatic Breast Cancer

Interventions

DRUG: Sirolimus for Injection (Albumin-bound)
DRUG: Fulvestrant Injection
DRUG: Placebo for Sirolimus for Injection (Albumin-bound)

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.